MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/00007890-200207270-00015

Медицинская библиотека · Transplantation · 2002

Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.

Ogawa Hiroyasu, Soma Toshihiro, Hosen Naoki, Tatekawa Toyoshi, Tsuboi Akihiro, Oji Yusuke, Tamaki Hiroya, Kawakami Manabu, Ikegame Kazuhiro, Murakami Masaki, Fujioka Tatsuya, Kim Eui Ho, Oka Yoshihiro, Sugiyama Haruo

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Graft-versus-host disease (GVHD) is still a major problem in allogeneic bone marrow transplantation (BMT). Prophylactic regimens used against GVHD in unrelated BMT, including cyclosporine (CsA)-plus-methotrexate (MTX), CsA-plus-MTX-plus-prednisone, and tacrolimus (FK506)-plus-MTX, are still unsatisfactory (34-70% occurrence of grades II-IV GVHD). To address this problem, we examined the efficacy of FK506-plus-MTX-plus-methylprednisolone (mPSL) in 20 patients who underwent BMT from unrelated donors.

METHODS

All patients received FK506 beginning the day before transplantation at a dose of 0.03 mg/kg per day by continuous intravenous (IV) infusion. MTX was administered at a dose of 10 mg/m(2) IV on day 1, and 7 mg/m(2) on days 3, 6, and 11. Intravenous administration of mPSL was started at a dose of 2 mg/kg per day on day 1. In the absence of acute GVHD, mPSL was gradually tapered from day 29.

RESULTS

Development of acute GVHD was almost completely suppressed (one patient with grade I, none with grades II-IV). However, the incidence and severity of chronic GVHD did not decrease. Eight of 12 patients with extensive chronic GVHD died of thrombotic microangiopathy or infection. A vigorous fluctuation (>100 U/mL per 10 days) of the soluble interleukin 2 receptor level in the serum after engraftment was highly related to the occurrence of chronic GVHD.

CONCLUSIONS

An FK506-plus(+)-MTX-plus(+)-mPSL prophylactic regimen could almost completely suppress acute GVHD but not chronic GVHD in unrelated BMT. In this GVHD prophylactic system, the extent of the change of soluble interleukin 2 receptor level may be a good predictor of development of chronic GVHD.

Для цитирования: Ogawa Hiroyasu, Soma Toshihiro, Hosen Naoki, Tatekawa Toyoshi, Tsuboi Akihiro, Oji Yusuke, Tamaki Hiroya, Kawakami Manabu, Ikegame Kazuhiro, Murakami Masaki, Fujioka Tatsuya, Kim Eui Ho, Oka Yoshihiro, Sugiyama Haruo. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.. Transplantation. 2002. DOI: 10.1097/00007890-200207270-00015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.